Abbonarsi

Validation of EncephalApp_Stroop as screening tool for the detection of minimal hepatic encephalopathy in German patients with liver cirrhosis - 28/05/22

Doi : 10.1016/j.clinre.2022.101873 
Leonard Kaps a, b, , Katharina Hildebrand a, b, Michael Nagel a, b, Maurice Michel a, b, Wolfgang Maximilian Kremer a, b, Max Hilscher a, b, Peter R. Galle a, b, Jörn M. Schattenberg a, Marcus-Alexander Wörns a, b, c, 1, Christian Labenz a, b, , 1
a Department of Internal Medicine I, University Medical Centre of the Johannes Gutenberg-University, Mainz, Germany 
b Cirrhosis Centre Mainz (CCM), University Medical Centre of the Johannes Gutenberg-University, Mainz, Germany 
c Department of Gastroenterology, Hematology, Oncology and Endocrinology, Klinikum Dortmund, Germany 

Corresponding authors at: Department of Internal Medicine I / Cirrhosis Centre Mainz (CCM), University Medical Centre of the Johannes Gutenberg-University, Langenbeckstraße 1, 55101 Mainz, Germany.Department of Internal Medicine I / Cirrhosis Centre Mainz (CCM)University Medical Centre of the Johannes Gutenberg-UniversityLangenbeckstraße 1Mainz55101Germany

Highlights

EncephalApp_Stroop (on+off time) discriminates between patients with and without minimal hepatic encephalopathy with an AUC of 0.87.
EncephalApp_Stroop may be useful as an initial screening tool in a stepwise diagnosis algorithm to reduce elaborate testing with PHES.
Results in EncephalApp_Stroop correlate well with PHES, while there is only a modest correlation with critical flicker frequency.

Il testo completo di questo articolo è disponibile in PDF.

Abstract

Background

In contrast to overt hepatic encephalopathy (OHE), the diagnosis of minimal HE (MHE) is challenging in patients with cirrhosis requiring elaborate, specialized testing. The EncephalApp_Stroop is a smartphone-based application established as screening tool for the diagnosis of MHE but has not yet been validated in a German cohort and country specific cut-offs are currently missing.

Methods

93 patients with cirrhosis were enroled into this study. Psychometric hepatic encephalopathy score (PHES) was used to detect MHE, and a subset of the patients was tested with critical flicker frequency (CFF). All patients underwent testing with EncephalApp_Stroop. Cut-off thresholds for EncephalApp_Stroop were calculated according to Youden's Index and a separate cut-off was determined with focus on sensitivity.

Results

24 (26%) patients had MHE according to PHES. EncephalApp_Stroop had a strong correlation with PHES (r=-0.76, p<0.001), while there was only a modest correlation with CFF (r=-0.51, <0.001). On time as well as on+off time discriminated best between patients with and without MHE with AUROCS of 0.87 for both measures. According to Youden's index, a cut-off of >224.7 s (sec) (on+off time) discriminated best between patients with and without MHE with a sensitivity of 71% and a specificity of 88%. The adjusted cut-off value for on+off time with focus on sensitivity (sensitivity:specificity weighed 2:1) was 185.1 s, yielding an optimized sensitivity of 92% and a negative predictive value of 96%. By using this cut-off as a pre-screening test in a stepwise diagnosis algorithm, elaborate testing with PHES could have been avoided in 49% of all patients.

Conclusion

EncephalApp_Stroop may be useful in a stepwise diagnosis algorithm or even as a stand-alone screening tool to detect MHE in German patients with cirrhosis.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : End-stage liver disease, Complications of cirrhosis, Hepatic encephalopathy, Point-of-care diagnostic, Smartphone-based testing, Psychometric hepatic encephalopathy score

Abbreviations : AUC, CCM, CFF, CHE, CI, DST, HCC, HE, HE1, IQR, MELD, MHE, NASH, NCT-A, NCT-B, NPV, HE, PHES, PPV, PSE, ROC, SDT, sec


Mappa


© 2022  Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 46 - N° 4

Articolo 101873- Aprile 2022 Ritorno al numero
Articolo precedente Articolo precedente
  • Pulmonary infection after hepatic resection: Associated factors and impact on outcomes
  • Yann Loncar, Nicolas Tartrat, Diane Lastennet, Louis Lemoine, Jean Christophe Vaillant, Eric Savier, Olivier Scatton, Benjamin Granger, Daniel Eyraud
| Articolo seguente Articolo seguente
  • An extracellular matrix-based signature associated with immune microenvironment predicts the prognosis of patients with hepatocellular carcinoma
  • Xinyun Zhang, Mengmeng Jiang, Xihao Zhang, Jinliang Zhang, Hongxing Guo, Chenxuan Wu

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2025 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.